[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100333021":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":13,"centralContacts":18,"locations":27,"responsibleParty":45,"collaborators":7,"id":47,"slug":48,"hasResults":49,"nctId":50,"briefTitle":51,"officialTitle":52,"acronym":53,"eligibilityCriteria":54,"healthyVolunteers":49,"sex":55,"minAge":56,"maxAge":7,"enrollmentInfo":57,"targetDuration":60,"studyType":61,"phases":7,"briefSummary":62,"conditions":63,"keywords":67,"overallStatus":30,"whyStopped":7,"lastUpdateSubmitDate":70,"lastUpdatePostDateStruct":71,"startDateStruct":74,"completionDateStruct":76,"leadSponsor":78,"locationsCount":79},{"fullName":5,"class":6},"University Hospital, Caen","OTHER",null,[9],{"type":10,"name":11,"description":12,"armGroupLabels":7,"otherNames":7},"DEVICE","pessary use","evaluation of satisfaction of pessary use in case of symptomatic genital prolapse",[14],{"name":15,"affiliation":16,"role":17},"Anne Cecile PIZZOFERRATO, MD","Universitary Hospital of Caen","PRINCIPAL_INVESTIGATOR",[19,23],{"name":15,"role":20,"phone":21,"phoneExt":7,"email":22},"CONTACT","+33231272723","acpizzofe@gmail.com",{"name":24,"role":20,"phone":25,"phoneExt":7,"email":26},"Anne VILLOT, MD","+33231272336","villot-a@chu-caen.fr",[28],{"facility":29,"status":30,"city":31,"state":7,"zip":32,"country":33,"countryCode":34,"cosmosGeoPoint":35,"geoPoint":40,"contacts":41},"Pizzoferato","RECRUITING","Caen","14000","France","FR",{"type":36,"coordinates":37},"Point",[38,39],-0.35912,49.18585,{"lat":39,"lon":38},[42],{"name":43,"role":20,"phone":25,"phoneExt":7,"email":44},"Anne Cecile Pizzoferrato, MD","pizzoferrato-ac@chu-caen.fr",{"type":46,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100333021","pessary-satisfaction-criteria-for-urogenital-prolapse-100333021",false,"NCT03615872","Pessary Satisfaction Criteria for Urogenital Prolapse","Evaluation of Patient Satisfaction With Pessary in the Treatment of Genital Prolapse","PeSaCUP","Inclusion Criteria:\n\n* The research protocol will be proposed to all patients with a symptomatic genital prolapse, over 18 years of age, who speak French and who agree to participate in this study\n* Prolapse defined according to the International Classification POP-Q-.\n\nExclusion Criteria:\n\n* Minors under 18 years of age\n* Pregnant or lactating women\n* Women Not speaking French (the good understanding of French is necessary to answer questionnaires and for informed information)\n* Women unable to understand due to cognitive impairment or degenerative disease (dementia\u002F Alzheimer's disease)","FEMALE","18 Years",{"count":58,"type":59},150,"ESTIMATED","5 Years","OBSERVATIONAL","Genital prolapse is a common pathology with a prevalence ranging from 2.9 to 11.4% or 31.8% to 97.7%, depending on whether a questionnaire or clinical examination is used. The use of pessary in the treatment of prolapse remains discussed despite a satisfaction rate of 50 to 80% in the literature and a minimal complications rate.\n\nThe main objective of this study is to assess the satisfaction of patients carrying a pessary in the first year after the laying.",[64,65,66],"Genital Prolapse","Pessary","Satisfaction",[68,69],"quality of life","efficiency","2024-09-19",{"date":72,"type":73},"2024-09-20","ACTUAL",{"date":75,"type":73},"2018-06-20",{"date":77,"type":59},"2025-06",{"name":5,"class":6},1]